PHARNEXT

Serial Number 88424864
Registration 6066907
700

Registration Progress

Application Filed
May 10, 2019
Under Examination
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered
Jun 2, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200602)
Due: Jun 02, 2026 160 days

Trademark Image

PHARNEXT

Basic Information

Serial Number
88424864
Registration Number
6066907
Filing Date
May 10, 2019
Registration Date
June 2, 2020
Published for Opposition
March 17, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 2, 2020
Registration
Registered
Classes
005 035 041 042
+1 more

Rights Holder

PHARNEXT

99
Address
11-13 rue René Jacques
ISSY-LES-MOULINEAUX 92130
FR

Ownership History

PHARNEXT

Original Applicant
99
ISSY-LES-MOULINEAUX FR

PHARNEXT

Owner at Publication
99
ISSY-LES-MOULINEAUX FR

PHARNEXT

Original Registrant
99
ISSY-LES-MOULINEAUX FR

Legal Representation

Attorney
Carlynn Ferguson Davis

USPTO Deadlines

Next Deadline
160 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200602)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Jun 2, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jan 12, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 2, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 12, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 12, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 4, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2020 ALIE A ASSIGNED TO LIE Loading...
Jan 29, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 1, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 25, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 25, 2019 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
May 22, 2019 ALIE A ASSIGNED TO LIE Loading...
May 15, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 14, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicine, namely, medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical products for human use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical preparations for human or veterinary use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; biological preparations for medical purposes for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; diagnostic preparations for medical diagnosis purposes; chemical preparations for medical purposes, namely, for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; food supplements and nutritional supplements for medical purposes; dietetic foods and beverages adapted for medical and pharmaceutical purposes; homeopathic and phyto-therapeutic supplements; disinfectants for hygiene purposes for medicine; bath preparations for medical purposes; dietetic beverages adapted for medical purposes; chemical reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medical soaps; plasters and gauze for dressings for medical purposes; medical dressings, except instruments
Class 035
Creation, compilation and management of databases and central data files in the field of pharmaceutical research and development, medicine, genetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of data in a central file in the field of pharmaceutical research and development, health and medicine; public relations in the field of health and medicine
Class 041
training services in the fields of health, pharmaceutical and medical research, pharmaceutical and medical development; publication of books and texts other than publicity texts in the pharmaceutical, medical and health fields; educational services, namely, arranging and conducting educational colloquiums, conferences, congresses, and seminars in the fields of pharmaceuticals, medical and health; teaching in the pharmaceutical, medical and health fields
Class 042
pharmaceutical products development; pharmaceutical research and development; conducting tests on pharmaceutical products; conducting clinical trials for pharmaceutical products for others; scientific research in the field of medicine; bioinformatics, chemical and biological analysis; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research and bioinformatics services in the field of chemical, biological and pharmaceutical products; software development and design in the field of pharmaceutical research, health and medicine; provision of scientific information relating to pharmaceutical products and medical and scientific research in the field of pharmaceuticals products and clinical trials; scientific research on chemical reagents for medical use, namely, biomarkers; pharmaceutical research services
Class 044
medical services; pharmaceutical advice services; pharmacy consultation; medical advisory and information services relating to pharmaceutical products; medical information services; provision of medical information; providing health information services on the treatment of diseases through an awareness program

Classification

International Classes
005 035 041 042 044